Seldon Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$372K Hold
404
0.14% 50
2025
Q4
$434K Hold
404
0.15% 44
2025
Q3
$308K Hold
404
0.11% 55
2025
Q2
$315K Hold
404
0.14% 48
2025
Q1
$334K Hold
404
0.21% 42
2024
Q4
$312K Hold
404
0.13% 53
2024
Q3
$358K Hold
404
0.2% 45
2024
Q2
$366K Hold
404
0.2% 40
2024
Q1
$314K Hold
404
0.19% 45
2023
Q4
$236K Hold
404
0.17% 49
2023
Q3
$217K Buy
+404
New +$208K 0.19% 49
2023
Q1
Sell
-404
Closed -$148K 162
2022
Q4
$148K Hold
404
0.13% 54
2022
Q3
$131K Hold
404
0.09% 59
2022
Q2
$131K Hold
404
0.08% 65
2022
Q1
$116K Hold
404
0.07% 90
2021
Q4
$112K Buy
+404
New +$102K 0.07% 101

Other funds holding LLY

Seldon Capital's LLY Position: Q1 2026 in Review

Seldon Capital held its Eli Lilly (LLY) position steady in Q1 2026 at 404 shares worth $372K. The position accounts for 0.14% of the portfolio, ranked #50.

Seldon Capital first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. The position peaked at $434K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Seldon Capital held 404 shares of Eli Lilly worth $372K as of Q1 2026.
  • Seldon Capital left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.14% of Seldon Capital's portfolio in Q1 2026, its #50 holding.
  • Seldon Capital first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
  • Seldon Capital's Eli Lilly position peaked at $434K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Seldon Capital's 13F filing for Q1 2026, filed 15 May 2026.